Impact of Ligand Protonation on Virtual Screening against β-Secretase (BACE1)
2007-11-26T00:00:00Z (GMT) by
Structure-based virtual screens were carried out against β-secretase (BACE1) to investigate the impact of ligand protonation on screening efficacy. A comparative evaluation of the performance and its dependence on ligand protonation states docking by Surflex, eHiTS, GOLD, and FlexX-Pharm was performed. Virtual screening performed by FlexX-Pharm (EF<sub>(1%)</sub>=69) and Surflex (EF<sub>(1%)</sub>=58) provided the best efficiency. Screening protocols by FlexX-Pharm and GOLD were affected by ligand protonation, while performance of Surflex did not depend on ligand protonation.
CC BY-NC 4.0